SlideShare ist ein Scribd-Unternehmen logo
1 von 2
Downloaden Sie, um offline zu lesen
FAST STATS                                                     NfWSWIRE
                                                                       Price of key materials used in                       population, according to the Centers for

                         23%                                           healthcare products expected
                                                                       to rise as credit crisis eases
                                                                       To help its 2,300 not-for-profit hospital
                                                                                                                            Disease Control and Prevention. The reas-
                                                                                                                            sessment is the latest signal that the Obama
                                                                                                                            administration is willing to reevaluate the
was how much lower the rate of hospital admis-
sions for heart attack was in 2007 compared to                         members better estimate supply cost in-              possible health impacts of chemicals that
2002, according to an analysis of Medicare data                        flation during their budget processes, the           have been in widespread use.
 published in the March 23 issue of the journal                        Premier healthcare alliance has released the           The FDA updated its website, www.fda.
                   Circulation.                                        March edition of its semiannual Economic             gov, with information about triclosan, a
                                                                       Outlook analysis. According to insights              common ingredient added to many con-
                                                                       from raw materials experts cited in the              sumer products to reduce or prevent bacte-
                     24.4%                                             analysis, in the next 12 months cotton,
                                                                       plastic and oil - three key materials used in
                                                                                                                            rial contamination.
                                                                                                                              In January, Rep. Edward J. Markey, chair-
   was the decrease in heart attack hospitaliza-                       many healthcare products - will experience           man of the House Energy and Commerce
tions for white men from 2002 to 2007, whereas                         price increases as the international economy         Subcommittee on Energy and the Environ-
 biack men experienced a smaller decline (18%).                        rebounds, the value of the dollar increases        ! ment, sent a letter to the FDA requesting in-
 Black women had a smalier deciine in heart at-                        and demand exceeds supply.
  tack hospitaiization rate compared with white
                                                                                                                            formation about the stahis of FDA's ongoing
    women (18.4% versus 23.3%, respectiveiy).                            As a result, annual market inflation               review of triclosan in consumer products.
                                                                       rates will increase on average between 1.6             In responding to the Chairman's letter,
                                                                       percent and 4.6 percent across categories            FDA explained that, in light of animal

                  228,170
fee-for-service Medicare patients were admitted
                                                                       such as cardiovascular services, facilities,
                                                                       imaging and nursing. Premier's existing
                                                                       contracts, excluding foodservice and phar-
                                                                                                                            studies raising questions about triclosan's
                                                                                                                            safety, the agency is engaged in an ongoing
                                                                                                                            scientific review to incorporate the most
  to the hospital for heart attack in 2007 com-
                                                                       macy, are expected to increase by about 1            up-to-date data and information into the
           pared with 297,653 in 2002.                                 percent on average in the next year, lower           regulations that govern consumer products
                                                                       than overall market increases which are              containing triclosan. The FDA does not have
                                                                       predicted to be an average of 3 percent              sufficient safety evidence to recommend

                   87,000
fewer heart-attack admissions occurred in 2007
                                                                       during this time frame.
                                                                         The Economic Outlook projects rates
                                                                       of inflation for the ensuing 12 months.
                                                                                                                            changing consumer use of products that
                                                                                                                            contain triclosan at this time.
                                                                                                                              For some consumer products, there is clear
 than would have been expected had the rate                            Premier produces a new analysis every six            evidence that triclosan provides a benefit.
              remained constant.                                       months to ensure projections are reflective          For other consumer products, FDA has not
                                                                       of changing market trends. The analysis              received evidence that the triclosan provides
                                                                       helps alert Premier alliance hospital mem-           an extra benefit to health. At this time, the
                300,000
    fewer heart attack admissions in all occurred
                                                                       bers to market forces that could drive price
                                                                       changes in the coming months and years.
                                                                       It compares Premier's contractual price
                                                                                                                            agency does not have evidence that triclosan
                                                                                                                            in antibacterial soaps and body washes pro-
                                                                                                                            vides any benefit over washing with regular
    over the six-year period covered in the study,                     protection against supplier price inflation          soap and water. For more information visit
     than if the rate had remained steady at the                       estimates to deliver a detailed estimate of        ¡ www.fda.gov/NewsEvents/Newsroom/
                      2002 level.                                      projected supply costs.                              PressAnnouncements/ ucm207833.htm
                                                                         The analysis includes accurate predictors        !
                                                                       of price inflation through an Inflation Cal-       I FDA requires device manufacturers
                        5.           0.
                                       0
  per year was the relative average annual de-
                                                                       culator in Premier's Supply Chain Advisor.
                                                                       The online calculator allows members to
                                                                                                                            to include information on
                                                                                                                            pédiatrie populations
                                                                       estimate their facility's total inflation impact     The FDA announced that they will begin
 cline in heart attack admissions between 2002
and 2007, after adjusting for factors such as age
                                                                       by taking into account individual utilization        implementing a requirement that device
                    and gender.                                        patterns and the price protection offered by       ' manufacturers provide readily available
                                                                       Premier's contracts. Visit www.premierinc.         I information in certain premarket applica-
                                                                       com for more information.                            tions on pédiatrie patients who suffer from

                        1964
was the year the U.S. Surgeon General issued a
                                                                       FDA says studies on triclosan,
                                                                       used in sanitizers and soaps,
                                                                                                                            the disease or condition that the device is
                                                                                                                            intended to treat, diagnose, or cure, even if
                                                                                                                            the device is intended for adult use.
report which linked cigarette smoking to signifi-                      raise concerns                                          Very few devices are developed or as-
 cantly higher death rates for cancer, cardiovas-                      The Food and Drug Administration said re-            sessed specifically for use in pédiatrie
 cular disease and other ailments. Since then, a                       cent research raises "valid concerns" about          patients, those 21 or younger at the time
 gradual decline in the percentage of Americans                        the possible health effects of triclosan, an       I of treatment or diagnosis. This effort will
 who smoke has been accompanied by a steady                            antibacterial chemical found in a growing          I provide a better understanding of which
 reduction in the death rate from heart disease,                       number of liquid soaps, hand sanitizers,           ! devices developed for use in adults should
        reported The Waii Street Journai.                              dishwashing liquids, shaving gels and even         ; be assessed or modified for use in pédiatrie
                                                                       socks, workout clothes and toys.                   ! populations. The requirements, contained
                                                                          The FDA and the Environmental Protec-             in the Food and Drug Administration
Source: "Recent Declines in Hospitalizations for Acute Myocardial
Infarction for Medicare Fee-for-Service Beneficiaries", Circulation,   tion Agency say they are taking a new                Amendments Act of 2007, will also improve
March 23, 2010; 121: 1322 - 1328. http://circahaiournals,org/          look at triclosan, which is so common that           the agency's ability to track the number
cgi/content/abstract/121/11/1322
                                                                       it is found in the urine of 75 percent of the        of approved devices for which there is a
                                                                                                                                          See NEWSWIRE on page 8
6    May 2010 • HtAlIUCARt PURCHASING N£WS • www.hpnonline.com
Copyright of Healthcare Purchasing News is the property of KSR Publishing and its content may not be copied
or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission.
However, users may print, download, or email articles for individual use.

Weitere ähnliche Inhalte

Ähnlich wie Triclosan news

Medical Devices Hit The Radar Screen. The Journal Of Healthcare Contracting
Medical Devices Hit The Radar Screen.   The Journal Of Healthcare ContractingMedical Devices Hit The Radar Screen.   The Journal Of Healthcare Contracting
Medical Devices Hit The Radar Screen. The Journal Of Healthcare ContractingWPM Enterprise
 
Acs0008 Health Care Economics The Broader Context
Acs0008 Health Care Economics The Broader ContextAcs0008 Health Care Economics The Broader Context
Acs0008 Health Care Economics The Broader Contextmedbookonline
 
Healthcare Perspective
Healthcare PerspectiveHealthcare Perspective
Healthcare Perspectivejonleiman
 
Analytics-Driven Healthcare: Improving Care, Compliance and Cost
Analytics-Driven Healthcare: Improving Care, Compliance and CostAnalytics-Driven Healthcare: Improving Care, Compliance and Cost
Analytics-Driven Healthcare: Improving Care, Compliance and CostCognizant
 
A SPECIAL S U P P L E H E N T TO THE HHTIHGS CENTEH REPOUT.docx
A SPECIAL S U P P L E H E N T TO THE HHTIHGS CENTEH REPOUT.docxA SPECIAL S U P P L E H E N T TO THE HHTIHGS CENTEH REPOUT.docx
A SPECIAL S U P P L E H E N T TO THE HHTIHGS CENTEH REPOUT.docxbartholomeocoombs
 
Medicines outlook through_2016_report (1)
Medicines outlook through_2016_report (1)Medicines outlook through_2016_report (1)
Medicines outlook through_2016_report (1)Juan Manuel Santa Maria
 
Clinical Trials & Statistical Tribulations
Clinical Trials & Statistical TribulationsClinical Trials & Statistical Tribulations
Clinical Trials & Statistical TribulationsBrian Attig
 
Testing times for clinical trials - Perscetives on personalised health care
Testing times for clinical trials - Perscetives on personalised health careTesting times for clinical trials - Perscetives on personalised health care
Testing times for clinical trials - Perscetives on personalised health careMats Sundgren
 
Improving Patient Safety with Disease Management – McKesson
Improving Patient Safety with Disease Management – McKessonImproving Patient Safety with Disease Management – McKesson
Improving Patient Safety with Disease Management – McKessonMcKesson Corporation
 
Improving Patient Safety - Five years after the IOM Report
Improving Patient Safety - Five years after the IOM ReportImproving Patient Safety - Five years after the IOM Report
Improving Patient Safety - Five years after the IOM ReportISOB
 
Pharmacovigilance at the Intersection of Healthcare and Life Sciences
Pharmacovigilance at the Intersection of Healthcare and Life SciencesPharmacovigilance at the Intersection of Healthcare and Life Sciences
Pharmacovigilance at the Intersection of Healthcare and Life SciencesPerficient
 
Stratified and Personalised Medicine
Stratified and Personalised MedicineStratified and Personalised Medicine
Stratified and Personalised MedicineEuroBioForum
 
Secrets To Success On The Journey To Meaningful Use
Secrets To Success On The Journey To Meaningful UseSecrets To Success On The Journey To Meaningful Use
Secrets To Success On The Journey To Meaningful UseCherian & Associates
 
Tengs Et Al Cost Effectiveness Of 500 Life Saving Interventions
Tengs Et Al   Cost Effectiveness Of 500 Life Saving InterventionsTengs Et Al   Cost Effectiveness Of 500 Life Saving Interventions
Tengs Et Al Cost Effectiveness Of 500 Life Saving Interventionsguestc704d9
 
Tengs Et Al Cost Effectiveness Of 500 Life Saving Interventions
Tengs Et Al   Cost Effectiveness Of 500 Life Saving InterventionsTengs Et Al   Cost Effectiveness Of 500 Life Saving Interventions
Tengs Et Al Cost Effectiveness Of 500 Life Saving Interventionsmyatom
 
Evidence of the value of the pharmacist
Evidence of the value of the pharmacistEvidence of the value of the pharmacist
Evidence of the value of the pharmacistRodmonster73
 
Effect of State Regulations on Health Insurance Premiums
Effect of State Regulations on Health Insurance PremiumsEffect of State Regulations on Health Insurance Premiums
Effect of State Regulations on Health Insurance PremiumseHealth , Inc.
 
Prescription Medicines Costs in Context January 2020
Prescription Medicines Costs in Context January 2020Prescription Medicines Costs in Context January 2020
Prescription Medicines Costs in Context January 2020PhRMA
 

Ähnlich wie Triclosan news (20)

Medical Devices Hit The Radar Screen. The Journal Of Healthcare Contracting
Medical Devices Hit The Radar Screen.   The Journal Of Healthcare ContractingMedical Devices Hit The Radar Screen.   The Journal Of Healthcare Contracting
Medical Devices Hit The Radar Screen. The Journal Of Healthcare Contracting
 
Acs0008 Health Care Economics The Broader Context
Acs0008 Health Care Economics The Broader ContextAcs0008 Health Care Economics The Broader Context
Acs0008 Health Care Economics The Broader Context
 
Healthcare Perspective
Healthcare PerspectiveHealthcare Perspective
Healthcare Perspective
 
Analytics-Driven Healthcare: Improving Care, Compliance and Cost
Analytics-Driven Healthcare: Improving Care, Compliance and CostAnalytics-Driven Healthcare: Improving Care, Compliance and Cost
Analytics-Driven Healthcare: Improving Care, Compliance and Cost
 
A SPECIAL S U P P L E H E N T TO THE HHTIHGS CENTEH REPOUT.docx
A SPECIAL S U P P L E H E N T TO THE HHTIHGS CENTEH REPOUT.docxA SPECIAL S U P P L E H E N T TO THE HHTIHGS CENTEH REPOUT.docx
A SPECIAL S U P P L E H E N T TO THE HHTIHGS CENTEH REPOUT.docx
 
Medicines outlook through_2016_report (1)
Medicines outlook through_2016_report (1)Medicines outlook through_2016_report (1)
Medicines outlook through_2016_report (1)
 
Clinical Trials & Statistical Tribulations
Clinical Trials & Statistical TribulationsClinical Trials & Statistical Tribulations
Clinical Trials & Statistical Tribulations
 
Testing times for clinical trials - Perscetives on personalised health care
Testing times for clinical trials - Perscetives on personalised health careTesting times for clinical trials - Perscetives on personalised health care
Testing times for clinical trials - Perscetives on personalised health care
 
FDA approvals 2012
FDA approvals 2012FDA approvals 2012
FDA approvals 2012
 
Improving Patient Safety with Disease Management – McKesson
Improving Patient Safety with Disease Management – McKessonImproving Patient Safety with Disease Management – McKesson
Improving Patient Safety with Disease Management – McKesson
 
Improving Patient Safety - Five years after the IOM Report
Improving Patient Safety - Five years after the IOM ReportImproving Patient Safety - Five years after the IOM Report
Improving Patient Safety - Five years after the IOM Report
 
Pharmacovigilance at the Intersection of Healthcare and Life Sciences
Pharmacovigilance at the Intersection of Healthcare and Life SciencesPharmacovigilance at the Intersection of Healthcare and Life Sciences
Pharmacovigilance at the Intersection of Healthcare and Life Sciences
 
Stratified and Personalised Medicine
Stratified and Personalised MedicineStratified and Personalised Medicine
Stratified and Personalised Medicine
 
Secrets To Success On The Journey To Meaningful Use
Secrets To Success On The Journey To Meaningful UseSecrets To Success On The Journey To Meaningful Use
Secrets To Success On The Journey To Meaningful Use
 
Tengs Et Al Cost Effectiveness Of 500 Life Saving Interventions
Tengs Et Al   Cost Effectiveness Of 500 Life Saving InterventionsTengs Et Al   Cost Effectiveness Of 500 Life Saving Interventions
Tengs Et Al Cost Effectiveness Of 500 Life Saving Interventions
 
Tengs Et Al Cost Effectiveness Of 500 Life Saving Interventions
Tengs Et Al   Cost Effectiveness Of 500 Life Saving InterventionsTengs Et Al   Cost Effectiveness Of 500 Life Saving Interventions
Tengs Et Al Cost Effectiveness Of 500 Life Saving Interventions
 
Evidence of the value of the pharmacist
Evidence of the value of the pharmacistEvidence of the value of the pharmacist
Evidence of the value of the pharmacist
 
Ira Klein, Can Value-based Contracting Work for Pharma Companies?
Ira Klein, Can Value-based Contracting Work for Pharma Companies?Ira Klein, Can Value-based Contracting Work for Pharma Companies?
Ira Klein, Can Value-based Contracting Work for Pharma Companies?
 
Effect of State Regulations on Health Insurance Premiums
Effect of State Regulations on Health Insurance PremiumsEffect of State Regulations on Health Insurance Premiums
Effect of State Regulations on Health Insurance Premiums
 
Prescription Medicines Costs in Context January 2020
Prescription Medicines Costs in Context January 2020Prescription Medicines Costs in Context January 2020
Prescription Medicines Costs in Context January 2020
 

Mehr von Genieve1

Hig sanid ambient 8 280 290 (2008)
Hig sanid ambient 8 280 290 (2008)Hig sanid ambient 8 280 290 (2008)
Hig sanid ambient 8 280 290 (2008)Genieve1
 
Propuesta org 302
Propuesta org 302Propuesta org 302
Propuesta org 302Genieve1
 
Dial triclosan
Dial triclosanDial triclosan
Dial triclosanGenieve1
 
Pro quest 1503217421
Pro quest 1503217421Pro quest 1503217421
Pro quest 1503217421Genieve1
 
Water issues
Water issuesWater issues
Water issuesGenieve1
 
Informe de agua
Informe de aguaInforme de agua
Informe de aguaGenieve1
 
Dallas water
Dallas waterDallas water
Dallas waterGenieve1
 
Reporte agua
Reporte aguaReporte agua
Reporte aguaGenieve1
 
Hig sanid ambient 8 335 342 (2008)
Hig sanid ambient 8 335 342 (2008)Hig sanid ambient 8 335 342 (2008)
Hig sanid ambient 8 335 342 (2008)Genieve1
 
1979 enero 3165_02
1979 enero 3165_021979 enero 3165_02
1979 enero 3165_02Genieve1
 

Mehr von Genieve1 (14)

Hig sanid ambient 8 280 290 (2008)
Hig sanid ambient 8 280 290 (2008)Hig sanid ambient 8 280 290 (2008)
Hig sanid ambient 8 280 290 (2008)
 
Articulo1
Articulo1Articulo1
Articulo1
 
Propuesta org 302
Propuesta org 302Propuesta org 302
Propuesta org 302
 
Dial triclosan
Dial triclosanDial triclosan
Dial triclosan
 
Articulo4
Articulo4Articulo4
Articulo4
 
Pro quest 1503217421
Pro quest 1503217421Pro quest 1503217421
Pro quest 1503217421
 
Water issues
Water issuesWater issues
Water issues
 
Informe de agua
Informe de aguaInforme de agua
Informe de agua
 
Dallas water
Dallas waterDallas water
Dallas water
 
Reporte agua
Reporte aguaReporte agua
Reporte agua
 
Hig sanid ambient 8 335 342 (2008)
Hig sanid ambient 8 335 342 (2008)Hig sanid ambient 8 335 342 (2008)
Hig sanid ambient 8 335 342 (2008)
 
Articulo2
Articulo2Articulo2
Articulo2
 
1979 enero 3165_02
1979 enero 3165_021979 enero 3165_02
1979 enero 3165_02
 
Articulo3
Articulo3Articulo3
Articulo3
 

Triclosan news

  • 1. FAST STATS NfWSWIRE Price of key materials used in population, according to the Centers for 23% healthcare products expected to rise as credit crisis eases To help its 2,300 not-for-profit hospital Disease Control and Prevention. The reas- sessment is the latest signal that the Obama administration is willing to reevaluate the was how much lower the rate of hospital admis- sions for heart attack was in 2007 compared to members better estimate supply cost in- possible health impacts of chemicals that 2002, according to an analysis of Medicare data flation during their budget processes, the have been in widespread use. published in the March 23 issue of the journal Premier healthcare alliance has released the The FDA updated its website, www.fda. Circulation. March edition of its semiannual Economic gov, with information about triclosan, a Outlook analysis. According to insights common ingredient added to many con- from raw materials experts cited in the sumer products to reduce or prevent bacte- 24.4% analysis, in the next 12 months cotton, plastic and oil - three key materials used in rial contamination. In January, Rep. Edward J. Markey, chair- was the decrease in heart attack hospitaliza- many healthcare products - will experience man of the House Energy and Commerce tions for white men from 2002 to 2007, whereas price increases as the international economy Subcommittee on Energy and the Environ- biack men experienced a smaller decline (18%). rebounds, the value of the dollar increases ! ment, sent a letter to the FDA requesting in- Black women had a smalier deciine in heart at- and demand exceeds supply. tack hospitaiization rate compared with white formation about the stahis of FDA's ongoing women (18.4% versus 23.3%, respectiveiy). As a result, annual market inflation review of triclosan in consumer products. rates will increase on average between 1.6 In responding to the Chairman's letter, percent and 4.6 percent across categories FDA explained that, in light of animal 228,170 fee-for-service Medicare patients were admitted such as cardiovascular services, facilities, imaging and nursing. Premier's existing contracts, excluding foodservice and phar- studies raising questions about triclosan's safety, the agency is engaged in an ongoing scientific review to incorporate the most to the hospital for heart attack in 2007 com- macy, are expected to increase by about 1 up-to-date data and information into the pared with 297,653 in 2002. percent on average in the next year, lower regulations that govern consumer products than overall market increases which are containing triclosan. The FDA does not have predicted to be an average of 3 percent sufficient safety evidence to recommend 87,000 fewer heart-attack admissions occurred in 2007 during this time frame. The Economic Outlook projects rates of inflation for the ensuing 12 months. changing consumer use of products that contain triclosan at this time. For some consumer products, there is clear than would have been expected had the rate Premier produces a new analysis every six evidence that triclosan provides a benefit. remained constant. months to ensure projections are reflective For other consumer products, FDA has not of changing market trends. The analysis received evidence that the triclosan provides helps alert Premier alliance hospital mem- an extra benefit to health. At this time, the 300,000 fewer heart attack admissions in all occurred bers to market forces that could drive price changes in the coming months and years. It compares Premier's contractual price agency does not have evidence that triclosan in antibacterial soaps and body washes pro- vides any benefit over washing with regular over the six-year period covered in the study, protection against supplier price inflation soap and water. For more information visit than if the rate had remained steady at the estimates to deliver a detailed estimate of ¡ www.fda.gov/NewsEvents/Newsroom/ 2002 level. projected supply costs. PressAnnouncements/ ucm207833.htm The analysis includes accurate predictors ! of price inflation through an Inflation Cal- I FDA requires device manufacturers 5. 0. 0 per year was the relative average annual de- culator in Premier's Supply Chain Advisor. The online calculator allows members to to include information on pédiatrie populations estimate their facility's total inflation impact The FDA announced that they will begin cline in heart attack admissions between 2002 and 2007, after adjusting for factors such as age by taking into account individual utilization implementing a requirement that device and gender. patterns and the price protection offered by ' manufacturers provide readily available Premier's contracts. Visit www.premierinc. I information in certain premarket applica- com for more information. tions on pédiatrie patients who suffer from 1964 was the year the U.S. Surgeon General issued a FDA says studies on triclosan, used in sanitizers and soaps, the disease or condition that the device is intended to treat, diagnose, or cure, even if the device is intended for adult use. report which linked cigarette smoking to signifi- raise concerns Very few devices are developed or as- cantly higher death rates for cancer, cardiovas- The Food and Drug Administration said re- sessed specifically for use in pédiatrie cular disease and other ailments. Since then, a cent research raises "valid concerns" about patients, those 21 or younger at the time gradual decline in the percentage of Americans the possible health effects of triclosan, an I of treatment or diagnosis. This effort will who smoke has been accompanied by a steady antibacterial chemical found in a growing I provide a better understanding of which reduction in the death rate from heart disease, number of liquid soaps, hand sanitizers, ! devices developed for use in adults should reported The Waii Street Journai. dishwashing liquids, shaving gels and even ; be assessed or modified for use in pédiatrie socks, workout clothes and toys. ! populations. The requirements, contained The FDA and the Environmental Protec- in the Food and Drug Administration Source: "Recent Declines in Hospitalizations for Acute Myocardial Infarction for Medicare Fee-for-Service Beneficiaries", Circulation, tion Agency say they are taking a new Amendments Act of 2007, will also improve March 23, 2010; 121: 1322 - 1328. http://circahaiournals,org/ look at triclosan, which is so common that the agency's ability to track the number cgi/content/abstract/121/11/1322 it is found in the urine of 75 percent of the of approved devices for which there is a See NEWSWIRE on page 8 6 May 2010 • HtAlIUCARt PURCHASING N£WS • www.hpnonline.com
  • 2. Copyright of Healthcare Purchasing News is the property of KSR Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use.